Pfizer acquires stake in Iteos Therapeutics
Pfizer Inc. has acquired a stake in Belgium-based pharmaceutical company Iteos Therapeutics, Belgian daily De Tijd reported, without citing any sources.
Pfizer will use Iteos' expertise in immunotherapy technology to develop new cancer treatments, the report said.
Iteos received EUR 24m, partly for its technology and partly as a capital injection, the report said. It did not given any other financial details or information about the size of the stake Pfizer acquired.
Source De Tijd, Company Press Release